24 April 2012 | News | By BioSpectrum Bureau
CCBC completes $50 mn convertible notes financing with Golden Meditech
Singapore: China Cord Blood Corporation (CCBC), the first and largest cord blood banking operator in China, has successfully completed the previously announced $50 million convertible note financing with Golden Meditech Holdings, a leading integrated healthcare enterprise in China and the Company's largest shareholder.
The board of directors of CCBC has appointed Mr. Yuen Kam, currently the Chairman and Chief Executive Officer of Golden Meditech, as a director and Chairman of CCBC, effective October 3, 2012. Ms. Ting Zheng will continue her role as a member of the CCBC board and Chief Executive Officer of the Company